This inventor holds 3 USPTO granted patents and 4 published patent applications and 2 EPO patents. Top assignees: Chiba University, Fujikura Kasei Co., Ltd.. Active years: 2016-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2016-2023
Title: Takaki Hiwasa: Innovator in Cancer and Arteriosclerosis Detection
Introduction
Takaki Hiwasa, an inventor based in Chiba, Japan, has made significant contributions to the fields of medical diagnostics. With a portfolio of three patents, his research primarily focuses on methods for detecting arteriosclerosis and certain types of cancer.
Latest Patents
Among his latest patents, Hiwasa introduced a groundbreaking method for detecting arteriosclerosis and cancer using the deoxyhypusine synthase (DHPS) gene as an indicator. This invention reveals that the DHPS gene, previously associated with prostate and cervical cancers, is also highly responsive to arteriosclerosis and digestive system cancers. The method involves detecting the expression of the DHPS gene in a test sample, preferably a blood sample, and determining the presence of arteriosclerosis or digestive system cancer based on increased gene expression.
Additionally, he developed a method for detecting the progression of arteriosclerosis. The aim of this patent is to establish a reliable marker to monitor the progression of arteriosclerosis directly. This involves determining the level of antibodies against the SH3BP5 protein in body fluid samples, thereby providing important data for preventing and treating arteriosclerosis-related diseases.
Career Highlights
Throughout his career, Takaki Hiwasa has collaborated with prominent companies in the field, such as Fujikura Kasei Co., Ltd. and the National University Corporation Chiba University. His innovative work has paved the way for advanced medical techniques and treatment methodologies.
Collaborations
Hiwasa has worked closely with notable colleagues, including Hideyuki Kuroda and Rika Nakamura. These collaborations highlight the teamwork and expertise involved in his research, facilitating groundbreaking advancements in the detection and treatment of critical health issues.
Conclusion
Takaki Hiwasa stands out as a vital contributor to the fields of cancer and arteriosclerosis research. His innovative patents and collaborative efforts not only enhance diagnostic methods but also have the potential to lead to significant advancements in prevention and treatment strategies, marking him as an influential figure in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile